Should I buy or sell Apollo Medical stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMEH shares. View AMEH analyst ratings or view top-rated stocks .

What is Apollo Medical's stock price target for 2024?

5 brokers have issued 12-month price objectives for Apollo Medical's stock. Their AMEH share price targets range from $41.00 to $55.00. On average, they expect the company's stock price to reach $47.20 in the next year. This suggests a possible upside of 15.6% from the stock's current price. View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts .

How have AMEH shares performed in 2024?

Apollo Medical's stock was trading at $38.30 at the start of the year. Since then, AMEH shares have increased by 6.6% and is now trading at $40.82. View the best growth stocks for 2024 here .

When is Apollo Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our AMEH earnings forecast .

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.35. The firm had revenue of $227.12 million for the quarter. Apollo Medical had a trailing twelve-month return on equity of 9.90% and a net margin of 3.56%. During the same period in the prior year, the firm earned $0.45 EPS.

What ETFs hold Apollo Medical's stock?

ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT) . iShares U.S. Healthcare Providers ETF (IHF) .

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical updated its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of 1.100-1.200 for the period, compared to the consensus EPS estimate of 1.200. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

What is Thomas Lam's approval rating as Apollo Medical's CEO?

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com . Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL) , SEA (SE) , Mastercard (MA) , NVIDIA (NVDA) , Walt Disney (DIS) , Lululemon Athletica (LULU) , Enphase Energy (ENPH) , Main Street Capital (MAIN) , Block (SQ) and Exxon Mobil (XOM) .

How do I buy shares of Apollo Medical?

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Apollo Medical have any subsidiaries?

The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc.. Read More

NASDAQ:AMEH

Apollo Medical (AMEH) Stock Price, News & Analysis

→ [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad)

Free AMEH Stock Alerts

$40.82

-0.88 (-2.11%)

(As of 02/23/2024)

Compare

Today's Range: $40.71
▼
$42.75
50-Day Range: $35.30
▼
$41.70
52-Week Range: $28.86
▼
$43.12

Volume: 313,900 shs
Average Volume: 166,711 shs
Market Capitalization: $2.38 billion

P/E Ratio: 40.82
Dividend Yield: N/A
Price Target: $47.20

Get Apollo Medical alerts:

Apollo Medical MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.80 Rating Score
Upside/Downside: 15.6% Upside
$47.20 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: -0.69
Upright™ Environmental Score
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 32.50%
From $1.20 to $1.59 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.63 out of 5 stars

Medical Sector

428th out of 914 stocks

Management Consulting Services Industry

11th out of 17 stocks

2.4

Analyst's Opinion

Consensus Rating
Apollo Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Apollo Medical has only been the subject of 3 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for AMEH.

0.0

Dividend Strength

Dividend Yield
Apollo Medical does not currently pay a dividend.
Dividend Growth
Apollo Medical does not have a long track record of dividend growth.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Apollo Medical has received a 64.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Health care management software" and "Management consulting for medical care" products. See details.
Environmental Sustainability
The Environmental Impact score for Apollo Medical is -0.69.

2.2

News and Social Media Coverage

News Sentiment
Apollo Medical has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Apollo Medical this week, compared to 1 article on an average week.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Apollo Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.46% of the stock of Apollo Medical is held by insiders.
Percentage Held by Institutions
Only 35.88% of the stock of Apollo Medical is held by institutions.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Apollo Medical are expected to grow by 32.50% in the coming year, from $1.20 to $1.59 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.58.
Price to Earnings Ratio vs. Sector
The P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 170.83.
Price to Earnings Growth Ratio
Apollo Medical has a PEG Ratio of 1.15. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Apollo Medical has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

Click here to learn more while there’s still time.

About Apollo Medical Stock (NASDAQ:AMEH)

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.

AMEH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AMEH Stock News Headlines

April 12, 2024 | forbes.com

Apollo Wearable Review — Better Sleep Is Possible

April 7, 2024 | msn.com

Apollo Spectra and Apollo One launch Boutique Healthcare Hub; To focus on elective procedures and preventive healthcare

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

March 19, 2024 | yahoo.com

Apollo Returns & More Must-See Moments from Married to Med's Season 10 Reunion Finale

February 29, 2024 | finance.yahoo.com

Astrana Health Full Year 2023 Earnings: EPS Beats Expectations

February 27, 2024 | finance.yahoo.com

Astrana Health Inc (ASTH) Reports Growth in Revenue and Net Income for Q4 and Full Year 2023

February 27, 2024 | msn.com

Jefferies Initiates Coverage of Apollo Medical Holdings (AMEH) with Buy Recommendation

February 26, 2024 | investorplace.com

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

February 26, 2024 | markets.businessinsider.com

Apollo Medical earnings preview: what Wall Street is expecting

February 23, 2024 | msn.com

B of A Securities Upgrades Apollo Medical Holdings (AMEH)

February 22, 2024 | msn.com

Apollo Medical to change name to Astrana Health

February 22, 2024 | msn.com

Apollo Medical upgraded to buy at BoA on revenue, earnings growth

February 22, 2024 | finance.yahoo.com

Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.

February 22, 2024 | prnewswire.com

Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.

February 20, 2024 | finance.yahoo.com

Apollo Medical Holdings, Inc. (AMEH) Reports Next Week: Wall Street Expects Earnings Growth

February 15, 2024 | finance.yahoo.com

AMEH May 2024 30.000 call

February 15, 2024 | finance.yahoo.com

AMEH May 2024 25.000 put

February 15, 2024 | wsj.com

Apollo Medical Holdings Inc.

February 14, 2024 | msn.com

Apollo Health moves to Oracle Fusion Cloud ERP for managing financial operations

February 8, 2024 | msn.com

Apollo PAT up 60% on robust growth across businesses

February 8, 2024 | investing.com

Apollo Medical Holdings Inc (AMEH)

February 8, 2024 | msn.com

Apollo Hospitals Q3 Results: Net profit rises 60% to Rs 245 crore

February 8, 2024 | finance.yahoo.com

An excellent week for Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) institutional owners who own 47% as one-year returns inch higher

January 31, 2024 | finance.yahoo.com

Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

January 30, 2024 | msn.com

ApolloMed and BASS partner to enhance value-based healthcare

January 29, 2024 | finanznachrichten.de

Apollo Medical Holdings, Inc.: ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

See More Headlines

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/04/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/06/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Management consulting services
Sub-Industry: N/A
Current Symbol: NASDAQ:AMEH
CUSIP: N/A
CIK: 1083446
Web: www.apollomed.net
Phone: (626) 282-0288
Fax: 818-839-5190
Employees: 1,362
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $47.20
High Stock Price Target: $55.00
Low Stock Price Target: $41.00
Potential Upside/Downside: +15.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.80
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.00
Trailing P/E Ratio: 40.82
Forward P/E Ratio: 34.02
P/E Growth: 1.15
Net Income: $45.17 million
Net Margins: 3.56%
Pretax Margin: 7.48%
Return on Equity: 9.90%
Return on Assets: 5.51%

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 2.35
Quick Ratio: 2.35

Sales & Book Value

Annual Sales: $1.14 billion
Price / Sales: 2.08
Cash Flow: $1.26 per share
Price / Cash Flow: 32.51
Book Value: $9.60 per share
Price / Book: 4.25

Miscellaneous

Outstanding Shares: 58,280,000
Free Float: 53,353,000
Market Cap: $2.38 billion
Optionable: Optionable
Beta: 1.04

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Kenneth T. Sim M.D. (Age 70)
Executive Chairman
Comp: $1.49M
Mr. Brandon Sim (Age 29)
President & CEO
Comp: $1.73M
Mr. Chandan Basho (Age 41)
CFO & COO
Comp: $581.42k
Dr. WaiChow Young M.D. (Age 77)
Chief Administrative Officer
Comp: $573.67k
Mr. John Vong (Age 51)
Chief Accounting Officer
Dr. Jeremy R. Jackson M.D.
Chief Quality Officer
Mr. Neil Ahuja
President of Provider Solutions
Yubin Park
Chief Data & Analytics Officer
Dr. Carlos Palacios M.D.
Chief Medical Officer for Texas
Dr. Dinesh M. Kumar M.D. (Age 55)
Chief Medical Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AMEH Stock Analysis - Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMEH shares.
View AMEH analyst ratings or view top-rated stocks.
What is Apollo Medical's stock price target for 2024?: 5 brokers have issued 12-month price objectives for Apollo Medical's stock. Their AMEH share price targets range from $41.00 to $55.00. On average, they expect the company's stock price to reach $47.20 in the next year. This suggests a possible upside of 15.6% from the stock's current price.
View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts.
How have AMEH shares performed in 2024?: Apollo Medical's stock was trading at $38.30 at the start of the year. Since then, AMEH shares have increased by 6.6% and is now trading at $40.82.
View the best growth stocks for 2024 here.
When is Apollo Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our AMEH earnings forecast.
How were Apollo Medical's earnings last quarter?: Apollo Medical Holdings, Inc. (NASDAQ:AMEH) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.35. The firm had revenue of $227.12 million for the quarter. Apollo Medical had a trailing twelve-month return on equity of 9.90% and a net margin of 3.56%. During the same period in the prior year, the firm earned $0.45 EPS.
What ETFs hold Apollo Medical's stock?: ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Apollo Medical issued on next quarter's earnings?: Apollo Medical updated its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of 1.100-1.200 for the period, compared to the consensus EPS estimate of 1.200. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.
What is Thomas Lam's approval rating as Apollo Medical's CEO?: 15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.
What other stocks do shareholders of Apollo Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).
How do I buy shares of Apollo Medical?: Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Apollo Medical have any subsidiaries?: The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..
Read More

This page (NASDAQ:AMEH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Apollo Medical (AMEH) Stock Price, News & Analysis

Apollo Medical MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Company Ownership

Earnings and Valuation

About Apollo Medical Stock (NASDAQ:AMEH)

AMEH Stock Price History

AMEH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

AMEH Stock Analysis - Frequently Asked Questions

Overall MarketRank^™